Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors

Japanese Journal of Cancer Research

Volumn 90, Issue 9, 1999, Pages 982-986

  Nakagawa, Hidewaki ^a,b   Koyama, Kumiko ^a   Monden, Morito ^b   Nakamura, Yusuke ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

APC homologue; APCL; Brain tumor

Indexed keywords

MESSENGER RNA;

ARTICLE; BRAIN TUMOR; CANCER GENETICS; CLINICAL ARTICLE; COLON POLYPOSIS; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION; GENE LOCUS; GLIOMA; GLIOMA CELL; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TELOMERE; TUMOR SUPPRESSOR GENE;

EID: 0032707134     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00845.x     Document Type: Article

References (17)

1. Nakagawa, H., Murata, Y., Koyama, K., Fujiyama, A., Miyoshi, Y., Monden, M., Akiyama, T. and Nakamura, Y. Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. Cancer Res., 58, 5176-5181 (1998).
2. Mori, T., Nagase, H., Horii, A., Miyoshi, Y., Shimano, T., Nakatsuru, S., Aoki, T., Arakawa, H., Yanagisawa, A., Ushio, Y. and Nakamura, Y. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosom. Cancer, 9, 168-172 (1994).
3. Hamilton, S. R., Liu, B., Parsons, R. E., Papadopoulos, N., Jen, J., Powell, S. M., Krush, A. J., Berk, T., Cohen, Z., Tetu, B., Burger, P. C., Wood, P. A., Taqi, F., Booker, S. V., Petersen, G. M., Offerhous, G. J. A., Tersmette, A. C., Giardiello, F. M., Vogelstein, B. and Kinzler, K. W. The molecular basis of Turcot's syndrome. N. Engl. J. Med., 332, 839-847 (1995).
4. Zurawel, R. H., Chiappa, S. A., Allen, C. and Raffel, C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res., 58, 896-899 (1998).
5. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., Linehan, W. M. and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91, 9700-9704 (1994).
6. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B. and Sidransky, D. 5′CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1, 686-692 (1995).
7. Ritland, S. R., Ganju, V. and Jenkins, R. B. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom. Cancer, 12, 277-282 (1995).
8. Weber, R. G., Sabel, M., Reifenberger, J., Sommer, C., Oberstrass, J., Reifenberger, G., Kiessling, M. and Cremer, T. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene, 13, 983-994 (1996).
9. Fults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A. and Cawthon, R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52, 674-679 (1992).
10. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A. and Louis, D. N. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56, 150-153 (1996).
11. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 275, 1943-1947 (1997).
12. Mollenhauer, J., Wiemann, S., Scheurlen, W., Korn, B., Hayashi, Y., Wilgenbus, K. K., von Deimling, A. and Poustka, A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat. Genet., 17, 32-39 (1997).
13. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15, 356-362 (1997).
14. Bhat, R. V., Baraban, J. M., Johnson, R. C., Eipper, B. A. and Mains, R. E. High levels of expression of the tumor suppressor gene APC during development of the rat central nervous system. J. Neurosci., 14, 3059-3071 (1994).
15. Matsumine, A., Ogai, A., Senda, T., Okumura, N., Satoh, K., Baeg, G.-H., Kawahara, T., Kobayashi, S., Okada, M., Toyoshima, K. and Akiyama, T. Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein. Science, 272, 1020-1023 (1996).
16. Senda, T., lino, S., Matsushita, K., Matsumine, A., Kobayashi, S. and Akiyama, T. Localization of the adenomatous polyposis coli tumor suppressor protein in the mouse central nervous system. Neuroscience, 83, 857-866 (1998).
17. Bhat, R. V., Axt, K. J., Fosnaugh, J. S., Smith, K. J., Johnson, K. A., Hill, D. E., Kinzler, K. W. and Baraban, J. M. Expression of the APC tumor suppressor protein in oligodendroglia. Glia, 17, 169-174 (1996).